# Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)

> **NCT00812812** · PHASE4 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** paroxetine 10mg tablet
- **DRUG:** paroxetine 20mg tablet
- **DRUG:** matched placebo to paroxetine 10mg
- **DRUG:** matched placebo to paroxetine 20mg

## Key facts

- **NCT ID:** NCT00812812
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812812, "Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00812812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*